| Authors: |
Sidana S; Department of Medicine, Stanford University School of Medicine, Stanford, CA., Ahmed N; Division of Hematology and Medical Oncology, Kansas University Medical Center, Kansas City, KS., Akhtar OS; Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI., Brazauskas R; Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI.; Division of Biostatics, Medical College of Wisconsin, Milwaukee, WI., Oloyede T; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI., Bye M; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI., Hansen D; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Ferreri C; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC., Freeman CL; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Afrough A; Department of Internal Medicine, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX., Anderson LD Jr; Department of Internal Medicine, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX., Dhakal B; Department of Medicine, Medical College of Wisconsin, Milwaukee, WI., Dhanda D; Bristol Myers Squibb, Summit, NJ., Gowda L; Department of Medicine, Yale Cancer Center, New Haven, CT., Hashmi H; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY., Harrison MJ; Bristol Myers Squibb, Summit, NJ., Kitali A; Bristol Myers Squibb, Summit, NJ., Landau H; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY., Mirza AS; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Patwardhan P; Bristol Myers Squibb, Summit, NJ., Qazilbash M; Department of Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, Houston, TX., Usmani S; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY., Patel K; Department of Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, Houston, TX., Nishihori T; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Ganguly S; Houston Methodist Neal Cancer Center, Houston, TX., Pasquini MC; Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI. |
